BTIG Maintains Buy on GEHC (GE HealthCare Technologies Inc.) Feb 04, 2026

BTIG maintained Buy on GEHC and raised its price target to $91 on Feb 04, 2026. This GEHC analyst rating follows GE HealthCare’s fourth-quarter 2025 results and signals continued conviction from BTIG. The change keeps a constructive stance while nudging upside expectations. Investors watching GE HealthCare Technologies Inc. should note the mix of a steady rating and a higher price target as a vote of confidence.